Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Diagnosis and Management of Fibromyalgia and Irritable Bowel Syndrome (IBS)

Introduction to Fibromyalgia and IBS Management

  • The European League Against Rheumatism recommends that fibromyalgia and IBS require prompt diagnosis, comprehensive assessment, and a graduated treatment approach focusing first on non-pharmacological therapies, followed by targeted pharmacological interventions when necessary 1, 2

Fibromyalgia Diagnosis and Management

  • The American College of Rheumatology suggests that fibromyalgia requires prompt diagnosis based on clinical presentation of chronic widespread pain, often accompanied by fatigue, sleep disturbance, and cognitive dysfunction 1
  • A comprehensive assessment should evaluate pain, function, and psychosocial context to recognize fibromyalgia as a complex condition with abnormal pain processing, as recommended by the European League Against Rheumatism 2
  • The American College of Rheumatology recommends providing clear patient education about the condition, including written materials explaining the nature of fibromyalgia 1
  • Aerobic and strengthening exercise is strongly recommended as the most effective non-pharmacological intervention for fibromyalgia by the American College of Sports Medicine 1, 2
  • The American Psychological Association suggests that cognitive behavioral therapy should be offered to all patients with fibromyalgia 1

IBS Diagnosis and Management

  • The National Institute for Health and Care Excellence recommends that IBS should be diagnosed based on symptoms of abdominal pain or discomfort associated with altered bowel habits for at least 6 months, in the absence of alarm symptoms or signs 3, 4
  • The British Society of Gastroenterology suggests that initial diagnostic workup should include full blood count, C-reactive protein or erythrocyte sedimentation rate, and coeliac serology; in patients under 45 years with diarrhea, fecal calprotectin should be measured to exclude inflammatory bowel disease 4
  • The American Gastroenterological Association recommends making a positive diagnosis of IBS based on symptoms without exhaustive investigation, as limited testing is sufficient to exclude common organic disorders 5, 6
  • The European Society of Gastrointestinal Endoscopy suggests that colonoscopy is not routinely indicated in IBS unless alarm symptoms/signs are present or in patients with IBS-D who have atypical features suggesting microscopic colitis 4, 6
  • The National Institute for Health and Care Excellence recommends establishing an effective doctor-patient relationship with clear communication about the gut-brain axis and validation of symptoms 7, 8
  • The American College of Sports Medicine suggests that regular exercise should be recommended to all patients with IBS 4

Pharmacological Management of Fibromyalgia and IBS

  • The American College of Rheumatology recommends low-dose amitriptyline as first-line pharmacotherapy for fibromyalgia 1, 2
  • The European League Against Rheumatism suggests that duloxetine or milnacipran can be used as alternatives for fibromyalgia 1
  • The American Gastroenterological Association recommends targeting treatment based on predominant symptoms (constipation, diarrhea, or pain) for IBS 5
  • The British Society of Gastroenterology suggests that for IBS-D, loperamide can be considered as first-line; rifaximin may be used as second-line therapy 5

Managing Comorbid Fibromyalgia and IBS

  • The American Psychological Association recommends considering brain-gut behavioral therapies such as cognitive behavioral therapy, gut-directed hypnotherapy, and mindfulness-based stress reduction for comorbid fibromyalgia and IBS 9
  • The National Institute for Health and Care Excellence suggests establishing appropriate referral thresholds to specialists (gastroenterologist, dietitian, psychologist) based on symptom severity and treatment response 7, 8

Common Pitfalls to Avoid

  • The American Gastroenterological Association recommends avoiding excessive diagnostic testing once a clinical diagnosis is established, as this can increase patient anxiety and healthcare costs 5, 6
  • The European Society of Gastrointestinal Endoscopy suggests not delaying initiation of treatment while pursuing extensive investigations 8
  • The American College of Rheumatology recommends avoiding setting unrealistic expectations; communicate that complete symptom resolution may not be achievable, but significant improvement in quality of life is possible 5
  • The National Institute for Health and Care Excellence suggests not neglecting psychological comorbidities, as untreated anxiety or depression can negatively affect treatment response 8, 10